GenMont Biotech Incorporation (TPE:3164)

TPE:3164 Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	143.25	110.51	55.6	133.69	169.95	274.85
Short-Term Investments	245.16	248.13	272.71	267.26	251.78	190.28
Cash & Short-Term Investments	388.42	358.64	328.3	400.94	421.73	465.13
Cash Growth	-0.24%	9.24%	-18.12%	-4.93%	-9.33%	-11.65%
Accounts Receivable	32.74	31.6	38.23	50.36	54.01	42.35
Other Receivables	2.29	1.73	1.79	1.4	1.05	4.09
Receivables	35.03	33.33	40.02	51.76	55.06	46.44
Inventory	74.21	77.67	88.12	55.3	37.06	34.79
Prepaid Expenses	6.32	4.92	9.07	13.49	66.94	49.59
Other Current Assets	68.6	67.17	-	-	-	-
Total Current Assets	572.57	541.73	465.51	521.5	580.79	595.94
Property, Plant & Equipment	1,039	1,037	1,060	1,113	1,045	922.68
Long-Term Investments	5.73	6.09	7.32	26.52	34.68	25.33
Other Intangible Assets	2.1	2.16	2.26	0.24	0.33	0.25
Long-Term Deferred Tax Assets	39	42.04	39.7	22.73	12.31	7.76
Other Long-Term Assets	80.79	79.89	78.29	11.59	24.8	60.86
Total Assets	1,739	1,709	1,653	1,696	1,698	1,613
Accounts Payable	7.33	6.3	7.85	14.37	11.39	7.39
Accrued Expenses	-	-	-	-	-	23.98
Short-Term Debt	21.39	20.48	-	-	-	-
Current Portion of Long-Term Debt	19.35	12.24	2.24	-	-	-
Current Portion of Leases	2.26	2.4	2.36	1.06	2.11	2.04
Current Income Taxes Payable	16.28	12.19	18.95	28.44	33.82	16.29
Current Unearned Revenue	41.68	40.05	33.98	25.76	25.33	24.3
Other Current Liabilities	114.04	46.48	81.01	91.16	66.51	20.96
Total Current Liabilities	222.32	140.15	146.39	160.78	139.17	94.96
Long-Term Debt	37.77	49.23	20.11	-	-	-
Long-Term Leases	33.73	34.26	33.6	33.49	30.62	32.29
Long-Term Deferred Tax Liabilities	3.11	3.11	1.59	1.96	1.54	1.39
Other Long-Term Liabilities	2.32	2.32	2.37	2.37	2.32	2.32
Total Liabilities	299.25	229.07	204.06	198.59	173.65	130.95
Common Stock	865.11	865.11	865.11	863.71	863.71	863.41
Additional Paid-In Capital	353.74	353.74	377.1	375.69	375.69	386.54
Retained Earnings	75.26	128.02	89.97	117.5	154.87	90.81
Comprehensive Income & Other	17.07	4.9	-15.88	-5.58	-17.83	-11.49
Total Common Equity	1,311	1,352	1,316	1,351	1,376	1,329
Minority Interest	128.31	127.9	132.82	145.89	147.95	152.6
Shareholders' Equity	1,439	1,480	1,449	1,497	1,524	1,482
Total Liabilities & Equity	1,739	1,709	1,653	1,696	1,698	1,613
Total Debt	114.49	118.61	58.31	34.55	32.73	34.33
Net Cash (Debt)	273.93	240.03	270	366.4	389	430.8
Net Cash Growth	-5.11%	-11.10%	-26.31%	-5.81%	-9.70%	-12.76%
Net Cash Per Share	3.16	2.77	3.12	4.23	4.48	4.89
Filing Date Shares Outstanding	86.51	86.51	86.51	86.37	86.37	86.34
Total Common Shares Outstanding	86.51	86.51	86.51	86.37	86.37	86.34
Working Capital	350.25	401.59	319.12	360.73	441.62	500.98
Book Value Per Share	15.16	15.63	15.22	15.65	15.94	15.40
Tangible Book Value	1,309	1,350	1,314	1,351	1,376	1,329
Tangible Book Value Per Share	15.13	15.60	15.19	15.64	15.93	15.39
Buildings	939.15	923.19	886.14	877.91	168.74	168.41
Machinery	493.96	489.48	481.71	419.15	234.11	230.98
Construction In Progress	0.02	0.02	0.03	75.24	858.62	720.57

Source: S&P Global Market Intelligence. Standard template. Financial Sources.